bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales

Go back to bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales
(NASDAQ: BIAF) Delayed: 0.49 --0 (-0%)
Previous Close $0.49    52 Week High
Open $0.49    52 Week Low
Day High $0.50    P/E N/A 
Day Low $0.46    EPS
Volume 197,437       

(NASDAQ: BIAFW) Delayed: 0.06 --0 (-0%)
Previous Close $0.06    52 Week High
Open $0.06    52 Week Low
Day High $0.06    P/E N/A 
Day Low $0.06    EPS
Volume 60